Results 211 to 220 of about 110,545 (302)
Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 [PDF]
Curiel, David T +5 more
core +1 more source
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz +8 more
wiley +1 more source
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade +7 more
wiley +1 more source
Characterization of difficult-to-remove host cell proteins in adeno-associated virus downstream processing. [PDF]
Leibiger TM, Min L, Lee KH.
europepmc +1 more source
Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors [PDF]
al., et +2 more
core +1 more source
Methodological validation of a cryo-TEM-based detection method for empty capsid ratio in recombinant adeno-associated virus. [PDF]
Xu L +11 more
europepmc +1 more source
The predawn dilemma in adeno-associated virus-based gene therapies for hereditary deafness. [PDF]
Zhou J, Deng D, Gan C, Du J, Zhao Y.
europepmc +1 more source

